Back to Search
DAVID BUCHSBAUM, M.D.
M.D.
Internal Medicine Physician
NPI: 1902963945Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
028787(VA)D0058384(MD)
Research & Publications (20)
Altered expression of 15-hydroxyprostaglandin dehydrogenase in tumor-infiltrated CD11b myeloid cells: a mechanism for immune evasion in cancer.
PMID 19494278·J Immunol·2009
7-preclinical
Therapy of head and neck squamous cell carcinoma with replicative adenovirus expressing tissue inhibitor of metalloproteinase-2 and chemoradiation.
PMID 18846112·Cancer Gene Ther·2009
4-observational
Polyethylene glycosylated curcumin conjugate inhibits pancreatic cancer cell growth through inactivation of Jab1.
PMID 19395473·Mol Pharmacol·2009
8-other
In vivo efficacy of marimastat and chemoradiation in head and neck cancer xenografts.
PMID 18931526·ORL J Otorhinolaryngol Relat Spec·2009
4-observational
Preclinical studies and clinical utilization of monoclonal antibodies in epithelial ovarian cancer.
PMID 19232697·Gynecol Oncol·2009
6-review
CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma.
PMID 19363468·Cancer Gene Ther·2009
7-preclinical
Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancer.
PMID 19509148·Clin Cancer Res·2009
7-preclinical
Effect of TRA-8 anti-death receptor 5 antibody in combination with chemotherapy in an ex vivo human ovarian cancer model.
PMID 19574765·Int J Gynecol Cancer·2009
8-other
Enhancement of glioma radiotherapy and chemotherapy response with targeted antibody therapy against death receptor 5.
PMID 18474311·Int J Radiat Oncol Biol Phys·2008
7-preclinical
Combination of treatment with death receptor 5-specific antibody with therapeutic HPV DNA vaccination generates enhanced therapeutic anti-tumor effects.
PMID 18598733·Vaccine·2008
7-preclinical
Molecular chemotherapy of pancreatic cancer using novel mutant bacterial cytosine deaminase gene.
PMID 18790765·Mol Cancer Ther·2008
7-preclinical
Immunohistochemistry in the evaluation of neovascularization in tumor xenografts.
PMID 18846440·Biotech Histochem·2008
4-observational
Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11.
PMID 18381960·Clin Cancer Res·2008
7-preclinical
Anti-tumor activity of the TRA-8 anti-DR5 antibody in combination with cisplatin in an ex vivo human cervical cancer model.
PMID 18177927·Gynecol Oncol·2008
8-other
Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging.
PMID 18922909·Cancer Res·2008
7-preclinical
Genetically designing a more potent antipancreatic cancer agent by simultaneously co-targeting human IL13 and EGF receptors in a mouse xenograft model.
PMID 18222985·Gut·2008
7-preclinical
Brief overview of preclinical and clinical studies in the development of intraperitoneal radioimmunotherapy for ovarian cancer.
PMID 17875801·Clin Cancer Res·2007
6-review
EGFR genomic gain and aberrant pathway signaling in pancreatic cancer patients.
PMID 17950068·J Surg Res·2007
8-other
TRA-8 anti-DR5 monoclonal antibody and gemcitabine induce apoptosis and inhibit radiologically validated orthotopic pancreatic tumor growth.
PMID 18089714·Mol Cancer Ther·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2929 HARDINGS TRACE LANE
RICHMOND, VA 23233 - Phone
- (804) 360-3610
Quick Facts
- NPI
- 1902963945
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile